Sekeres MA, Montesinos P, Novak J, Wang J, et al. Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial. Leukemia 2023 Aug 21. doi: 10.1038/s41375-023-02001.
PMID: 37604981